HealthPrize partners with pharma and payers to enable people with chronic conditions to take control of their treatment plan and improve their health outcomes

Norwalk, CT
Joined August 2010
A case study from @HealthPrize reports that patients on its program for a COPD therapy were more adherent than a control group. Read the details in this week's #KlickWire: bit.ly/3QLQcY8
1
1
.@Boehringer digital rewards club boosts #COPD #medicationadherence by 44%: study - promise of free credits to a favorite retailer is enough to help them stick to a medication regimen. @HealthPrize buff.ly/3Ae7FTN
1
2
HealthPrize retweeted
An interesting perspective from @TheEconomist. Language matters. #medicine #cancer #digitalhealth #PatientCare
1
7
1
10
Happy to present our @HealthPrize data in collaboration with @boehringerus : 44% increase in medication adherence for patients with #COPD compared to matched controls. Most adherence interventions deliver single-digit increases. #ATS2022
4
4
Congratulations to Jenna Lee on her recent promotion to Senior Program Operations Manager. Working to improve patient health and program performance, Jenna defines success with two distinct hats: her customer hat and her end-user hat!
1
2
HealthPrize retweeted
HealthPrize and @wegohealth asked patient influencers within the #cancer community if rewards-based adherence programs are appropriate for patients taking chronic #oncology medications: hubs.li/H0xBDTt0 by @HealthPrize
2
2
.@HealthPrize pharma adherence programs result in a 52% mean lift across therapeutic areas - Watch this 5-minute webinar to find out how, and what they can do for you. ow.ly/qEIh50Bf0zC #ad
1
3
HealthPrize retweeted
While rewards-based medication #adherence programs are common for chronic diseases, they have not been used in #oncology. To see if #cancer #patients would like such programs, John Monahan and Katrina Firlik of @HealthPrize asked eight patient influencers: bit.ly/2QsqYB3
1
2
#PRESS: Boehringer Ingelheim and @LillyPad share positive results from Phase III #heartfailure trial in people with and without #T2D: bit.ly/2P7Sfbd
1
45
3
62
How are apps to take your meds affecting adherence? I heard from @GrooveHealthRx @HealthPrize @OmriShor @MediSafeApp @PhRMA. bit.ly/3f6p2rP #adherence #pharma
1
2
Digital Pharma Week kicks off TODAY at 1:00PM with Digital Pharma Day! Register for free here: bit.ly/3fqQcdq We look forward to seeing you online soon! #DPWeek #DigitalPharmaWeek #DigPharma #PharmaMarketing
1
1
HealthPrize retweeted
Jayne Gershkowitz, Chief Patient Advocate, @amicusrx1 is one of 52 #womenleaders featured in The Women of the Week: A 2019 Anthology, out new today! Read her story and all the others as they outline their career journeys and the lessons learned. #IWD2020 pharmavoice.com/ebook/women-…
HealthPrize retweeted
Read all about these 52 amazing #womenleaders, their unique career journeys and their lessons shared in The Women of the Week: A 2019 Anthology, just out TODAY! Don’t miss the #WoW profile of Laurie Bartolomeo, EVP, Creative Dir., @DudnykHealth. #IWD2020 pharmavoice.com/ebook/women-…
1
1
Ro to launch new weight management service. #PatientEngagement #DigitalHealth bit.ly/2M5eddY
3
5
Replying to @chrissyfarr
Technology does not help adherence. A pill reminder...a digital pill...Non-adherence is a behavioral issue that has nothing to do with reminders. Some people do not take their meds because they don’t want to accept they are sick. Check out @HealthPrize for example. – at Lakes by the Bay, FL
5
1
1
13
One of my personal #HLTH faves: this panel of Chief Digital Officers of the largest pharma companies is majority female. Nice job @GSK, @pfizer, and @HLTHEVENT and even more so to these kickass women moving forward pharma’s digital revolution 💪👩‍💻👩‍🔬👩‍⚕️ 💪
5
1
14
.@Pfizer chief digital officer Lidia Fonseca at @HLTHEVENT: "Pharma has leveraged digital for efficiency gains w/ some modest results. What we're trying to do now is disrupt the model + ourselves. It's not going to be a startup that will shake us up; it's going to be us."
3
12
“Gamification works for everyone,” Tom Kottler, CEO of @HealthPrize says. Levels of engagement and medication adherence have been incredibly similar across all ages, genders, races, etc. #MIS2019
1
1